Carvedilol and Silymarin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Carvedilol (carvedilol) and Silymarin (milk thistle). Common drug interactions include contusion among females and aspartate aminotransferase increased among males.

The phase IV clinical study analyzes what interactions people have when they take Carvedilol and Silymarin. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Carvedilol?

Carvedilol has active ingredients of carvedilol. It is often used in high blood pressure. eHealthMe is studying from 112,649 Carvedilol users. Check the latest studies of Carvedilol.

What is Silymarin?

Silymarin has active ingredients of milk thistle. eHealthMe is studying from 793 Silymarin users. Check the latest studies of Silymarin.

On Aug, 05, 2026

12 people who take Carvedilol and Silymarin together, and have interactions are studied.

Carvedilol and Silymarin drug interactions.

What are the common drug interactions of Carvedilol and Silymarin, by gender? *:

female:

Contusion (a type of hematoma of tissue in which capillaries)
Diarrhoea
Vision blurred
Vitreous haemorrhage (intraocular (inside the eye) bleeding)

male:

Aspartate aminotransferase increased
Diarrhoea
Hepatocellular carcinoma (liver cancer)
Haematemesis (vomiting of blood)
Melaena (the passage of black, tarry stools)
Upper gastrointestinal haemorrhage (upper gastrointestinal bleeding)
Gastroenteritis (inflammation of stomach and intestine)
Hepatic failure (liver failure)
Hypokalaemia (low potassium)
Liver carcinoma ruptured (ruptured liver cancer tumour)

What are the common drug interactions of Carvedilol and Silymarin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Aspartate aminotransferase increased
Diarrhoea
Hepatic failure (liver failure)
Hypokalaemia (low potassium)
Liver carcinoma ruptured (ruptured liver cancer tumour)
Abdominal pain

50-59:

Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Pancreatic carcinoma (pancreatic cancer)
Anaemia (lack of blood)

60+:

Cardiogenic shock (inadequate circulation of blood)
Hepatocellular carcinoma (liver cancer)
Haematemesis (vomiting of blood)
Melaena (the passage of black, tarry stools)
Upper gastrointestinal haemorrhage (upper gastrointestinal bleeding)
Contusion (a type of hematoma of tissue in which capillaries)
Gastroenteritis (inflammation of stomach and intestine)
Vision blurred
Vitreous haemorrhage (intraocular (inside the eye) bleeding)

What are the existing conditions these people have? *

Abdominal Pain: 7 people, 58.33%
Nausea (feeling of having an urge to vomit): 6 people, 50.00%
Weakness: 4 people, 33.33%
Liver Carcinoma Ruptured (ruptured liver cancer tumour): 4 people, 33.33%
Headache (pain in head): 4 people, 33.33%
Hepatic Failure (liver failure): 4 people, 33.33%
Hepatic Neoplasm Malignant (liver cancer): 4 people, 33.33%
Hepatitis B: 4 people, 33.33%
Hypoalbuminaemia (levels of albumin in blood serum are abnormally low): 4 people, 33.33%
Gastritis (inflammation of stomach): 4 people, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take Carvedilol and Silymarin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously